Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension

被引:12
作者
Godinas, Laurent [1 ,2 ,3 ,4 ]
Amar, David [1 ,2 ,3 ]
Montani, David [1 ,2 ,3 ]
Lau, Edmund M. [1 ,2 ,3 ,5 ]
Jai's, Xavier [1 ,2 ,3 ]
Savale, Laurent [1 ,2 ,3 ]
Jevnikar, Mitja [1 ,2 ,3 ]
Sitbon, Olivier [1 ,2 ,3 ]
Simonneau, Gerald [1 ,2 ,3 ]
Humbert, Marc [1 ,2 ,3 ]
Laveneziana, Pierantonio [1 ,2 ,3 ,6 ,7 ]
Garcia, Gilles [1 ,2 ,3 ]
机构
[1] Hop Bicetre, AP HP, Ctr Referencedel Hypertens Pulmonaire Severe, Dept Hosp Univ Thorax Innovat,Serv Pneumol, Le Kremlin Bicetre, France
[2] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France
[3] Univ Paris Sud, Lab Excellence Rech Medicament & Innovat Therapeu, INSERM, UMR S 999,Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France
[4] Univ Catholique Louvain Mt Godinne, Ctr Hosp Univ, Dept Pneumol, Yvoir, Belgium
[5] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia
[6] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Serv Explorat Fonct Respirat Exercice & Dyspnee, Dept R3S, Paris, France
[7] Univ Paris 06, Sorbonne Univ, INSERM, Unite Med Rech Sci Neurophysiol Resp Expt & Clin, Paris, France
关键词
lung capillary blood volume; membrane diffusion; pulmonary veno-occlusive disease; chronic thromboembolic disease; pulmonary arterial hypertension; VENOOCCLUSIVE DISEASE; ARTERIAL-HYPERTENSION; CARBON-MONOXIDE; CAPACITY; CO; NO;
D O I
10.1016/j.healun.2015.12.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Combined diffusion capacity of the lung for carbon monoxide (DLco) and nitric oxide (DLNO) measurements allow for the estimation of pulmonary capillary blood volume (Vc) and alveolar membrane diffusion (Dm). The clinical usefulness of these measurements in pulmonary hypertension (PH) is unclear. METHODS: Combined DLCO and DLNO were measured in 290 consecutive patients with precapillary PH (pulmonary arterial hypertension (PAH), n = 153; pulmonary veno-occlusive disease (PVOD), 72 = 33; and chronic thromboembolic pulmonary hypertension (CTEPH), 72 = 104). Clinical correlates of Vc and Dm were assessed in a sub-group of PAH patients without comorbidities. RESULTS: PVOD patients compared with PAH and CTEPH patients displayed the lowest values of Ye (29.4 +/- 16.8 ml vs 56.3 +/- 26.5 ml vs 56.9 +/- 26.2 ml, p < 0.01, respectively) and Dm (27.7 +/- 11.6 ml/mm Hg/min vs 43.4 +/- 14.8 ml/mm Hg/min vs 44.7 +/- 17.7 ml/mm Hg/min, p < 0.01, respectively). The DLNO/DLCO ratio was highest in the PVOD group (5.82 +/- 2.04 vs 4.95 +/- 1.31 vs 5.16 +/- 1.58, p < 0.05). In a sub-set of 69 PAH patients without comorbidities, Ve and Dm correlated significantly with functional capacity (6-minute walking distance, oxygen consumption) and New York Heart Association Functional Classification but not with invasive hemodynamics. Only Dm was significantly associated with survival. On receiver operating characteristic curve analysis, Vc, Dm, and DLNO/DLCO were not superior to DLCO for discriminating PVOD from PAH or CTEPH. CONCLUSIONS: PVOD patients display higher values of the DLNO/DLCO ratio compared with PAH and CTEPH, suggesting proportionally greater reduction in Vc relative to Dm. However, partitioning of diffusion failed to be more clinically relevant than conventional DLCO for detection of PVOD. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:647 / 656
页数:10
相关论文
共 34 条
[1]   European reference equations for CO and NO lung transfer [J].
Aguilaniu, B. ;
Maitre, J. ;
Gienet, S. ;
Gegout-Petit, A. ;
Guenard, H. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (05) :1091-1097
[3]   Reduction of pulmonary capillary blood volume in patients with severe unexplained pulmonary hypertension [J].
Borland, C ;
Cox, Y ;
Higenbottam, T .
THORAX, 1996, 51 (08) :855-856
[4]  
Borland C.D., 1985, J APPL PHYSIOL, V108, P1052
[5]  
Ceridon ML, 1985, J APPL PHYSIOL, V2010, P643
[6]   Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension [J].
Chandra, Sonal ;
Shah, Sanjiv J. ;
Thenappan, Thenappan ;
Archer, Stephen L. ;
Rich, Stuart ;
Gomberg-Maitland, Mardi .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02) :181-187
[7]   Severe pulmonary hypertension and chronic obstructive pulmonary disease [J].
Chaouat, A ;
Bugnet, AS ;
Kadaoui, N ;
Schott, R ;
Enache, I ;
Ducoloné, A ;
Ehrhart, M ;
Kessler, R ;
Weitzenblum, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (02) :189-194
[8]   Microvascular disease in chronic thromboernbolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature [J].
Dorfmueller, Peter ;
Guenther, Sven ;
Ghigna, Maria-Rosa ;
de Montpreville, Vincent Thomas ;
Boulate, David ;
Paul, Jean-Francois ;
Jais, Xavier ;
Decante, Benoit ;
Simonneau, Gerald ;
Dartevelle, Philippe ;
Humbert, Marc ;
Fadel, Elie ;
Mercier, Olaf .
EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (05) :1275-1288
[9]   EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension [J].
Eyries, Melanie ;
Montani, David ;
Girerd, Barbara ;
Perret, Claire ;
Leroy, Anne ;
Lonjou, Christine ;
Chelghoum, Nadjim ;
Coulet, Florence ;
Bonnet, Damien ;
Dorfmueller, Peter ;
Fadel, Elie ;
Sitbon, Olivier ;
Simonneau, Gerald ;
Tregouet, David-Alexandre ;
Humbert, Marc ;
Soubrier, Florent .
NATURE GENETICS, 2014, 46 (01) :65-+
[10]   Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension [J].
Farha, Samar ;
Laskowski, Daniel ;
George, Deepa ;
Park, Margaret M. ;
Tang, W. H. Wilson ;
Dweik, Raed A. ;
Erzurum, Serpil C. .
RESPIRATORY RESEARCH, 2013, 14